[go: up one dir, main page]

AU2003207528A8 - Method of detecting t-cell proliferation for diagnosis of diseases by gene array - Google Patents

Method of detecting t-cell proliferation for diagnosis of diseases by gene array

Info

Publication number
AU2003207528A8
AU2003207528A8 AU2003207528A AU2003207528A AU2003207528A8 AU 2003207528 A8 AU2003207528 A8 AU 2003207528A8 AU 2003207528 A AU2003207528 A AU 2003207528A AU 2003207528 A AU2003207528 A AU 2003207528A AU 2003207528 A8 AU2003207528 A8 AU 2003207528A8
Authority
AU
Australia
Prior art keywords
diagnosis
diseases
detecting
cell proliferation
gene array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003207528A
Other versions
AU2003207528A1 (en
Inventor
Ying Zang
Shong Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAXX GENETECH CO Ltd
Original Assignee
MAXX GENETECH CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAXX GENETECH CO Ltd filed Critical MAXX GENETECH CO Ltd
Publication of AU2003207528A1 publication Critical patent/AU2003207528A1/en
Publication of AU2003207528A8 publication Critical patent/AU2003207528A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003207528A 2002-01-09 2003-01-08 Method of detecting t-cell proliferation for diagnosis of diseases by gene array Abandoned AU2003207528A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HK02100156 2002-01-09
CNHK02100156.8 2002-01-09
PCT/US2003/000882 WO2003059155A2 (en) 2002-01-09 2003-01-08 Method of detecting t-cell proliferation for diagnosis of diseases by gene array

Publications (2)

Publication Number Publication Date
AU2003207528A1 AU2003207528A1 (en) 2003-07-30
AU2003207528A8 true AU2003207528A8 (en) 2003-07-30

Family

ID=10945400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003207528A Abandoned AU2003207528A1 (en) 2002-01-09 2003-01-08 Method of detecting t-cell proliferation for diagnosis of diseases by gene array

Country Status (3)

Country Link
CN (1) CN1688708A (en)
AU (1) AU2003207528A1 (en)
WO (1) WO2003059155A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101431312B1 (en) 2003-06-27 2014-08-20 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Method of selecting wt1 vaccine adaptive patient
WO2005084134A2 (en) * 2004-03-04 2005-09-15 Dena Leshkowitz Quantifying and profiling antibody and t cell receptor gene expression
KR101669279B1 (en) 2007-03-05 2016-10-26 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
GB2483810B (en) 2008-11-07 2012-09-05 Sequenta Inc Methods for correlating clonotypes with diseases in a population
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
PT2387627E (en) 2009-01-15 2016-06-03 Adaptive Biotechnologies Corp Adaptive immunity profiling and methods for generation of monoclonal antibodies
JP2012531202A (en) 2009-06-25 2012-12-10 フレッド ハチンソン キャンサー リサーチ センター How to measure adaptive immunity
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
CN103764826A (en) 2011-06-28 2014-04-30 株式会社癌免疫研究所 Peptide Cancer Antigen-Specific T Cell Receptor Gene
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
EP2768982A4 (en) 2011-10-21 2015-06-03 Adaptive Biotechnologies Corp QUANTIFICATION OF GENOMES OF ADAPTIVE IMMUNE CELLS IN A COMPLEX MIXTURE OF CELLS
CN102373206B (en) * 2011-10-31 2013-02-27 暨南大学 PPP2R5C-siRNA799 targeted to inhibit PPP2R5C gene expression and tumor T cell proliferation and its application
AU2012347460B2 (en) 2011-12-09 2017-05-25 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
JP6302847B2 (en) 2012-03-05 2018-03-28 アダプティヴ バイオテクノロジーズ コーポレーション Determination of paired immunoreceptor chains from frequency matched subunits
ES2711156T3 (en) 2012-05-08 2019-04-30 Adaptive Biotechnologies Corp Method to measure and calibrate the amplification bias in multiplexed PCR reactions
EP2904111B1 (en) 2012-10-01 2017-12-06 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US20170292149A1 (en) 2014-03-05 2017-10-12 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (en) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Quantification of adaptive immune cell genomes in a complex mixture of cells
WO2016069886A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corporation Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
CA2968543C (en) 2014-11-25 2024-04-02 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
WO2016138122A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
WO2016161273A1 (en) 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
EP3347051A4 (en) * 2015-09-10 2019-04-24 Affigen, Inc. Sequencing-directed selection of tumor theranostics
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US20020107388A1 (en) * 2000-05-12 2002-08-08 Vandenbark Arthur A. Methods of identifying and monitoring disease-associated T cells

Also Published As

Publication number Publication date
AU2003207528A1 (en) 2003-07-30
CN1688708A (en) 2005-10-26
WO2003059155A2 (en) 2003-07-24
WO2003059155A3 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2003207528A8 (en) Method of detecting t-cell proliferation for diagnosis of diseases by gene array
AU2003210707A1 (en) Apparatus for synthesis of arrays of dna probes
IL163600A0 (en) Methods for detection of genetic disorders
AU2003301347A1 (en) Methods for monitoring treatment of disease
SG123650A1 (en) Yield analysis method
AU2003256407A1 (en) Method of preparing high specific activity platinum-195m
AU2003280991A1 (en) Method for diagnosis of intestinal-type gastric tumors
AU2003273335A1 (en) Method for testing drug susceptibility of hiv
AU2003212245A8 (en) Method of diagnosis of inflammatory diseases using calgranulin c
AU2003212246A1 (en) Method for diagnosis of inflammatory diseases using mrp8/mrp14
EP1570074A4 (en) Genotyping of deafness by oligonucleotide microarray analysis
AU2003214560A1 (en) Test for measurement of therapeutic drug levels
AU2003285583A1 (en) Oligonucleotide guided analysis of gene expression
AU2003294206A8 (en) Methods for diagnosing htlv-i-mediated diseases
AU2003277600A8 (en) Method for quick diagnosis of kidney diseases
AU2003293382A8 (en) Methods for identifying the activity of gene products
WO2004042371A1 (en) Method for quick diagnosis of kidney diseases
GB0200239D0 (en) Method for detecting human papillomavirus mRNA
AU2003263728A1 (en) Method for diagnosis of cancer
AU2003263339A8 (en) System for improved biological age measurement
EP1641934A4 (en) Methods for enhancing gene expression analysis
GB0207113D0 (en) Support array for transducers
AU2003266711A1 (en) Method of detecting hybridization
AU2003205285A1 (en) Apparatus for facilitating analysis of dream activity
AU2003215034A8 (en) Diagnostic method for spectroscopic detection of tuberculosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase